US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist
  • 4.590
  • -0.340-6.90%
Close Apr 18 16:00 ET
  • 4.690
  • +0.100+2.18%
Post 18:50 ET
550.52MMarket Cap-2105P/E (TTM)

About Prime Medicine Company

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Company Profile

SymbolPRME
Company NamePrime Medicine
Listing DateOct 20, 2022
Issue Price17.00
Founded2019
CEODr. Keith Gottesdiener, M.D.
MarketNASDAQ
Employees234
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address21 Erie Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-564-0013
Websitehttp://www.primemedicine.com

Company Executives

  • Name
  • Position
  • Salary
  • Andrew Anzalone, M.D.,PhD
  • Co-Founder and Head of Prime Editing Platform
  • --
  • Dr. Keith Gottesdiener, M.D.
  • President, Chief Executive Officer and Director
  • 924.04K
  • Richard H. Brudnick
  • Chief Business Officer
  • 1.44M
  • Dr. Allan Reine, M.D.
  • Chief Financial Officer
  • --
  • Dr. Ann L. Lee, PhD
  • Chief Technical Officer
  • 947.28K
  • Carman Alenson
  • Senior Vice President, Finance and Chief Accounting Officer
  • --
  • Dr. Jeremy Duffield
  • Chief Scientific Officer
  • --
  • Dr. Meredith Goldwasser
  • Senior Vice President, Strategy and Corporate Operations
  • --
  • Jeffrey D. Marrazzo
  • Director
  • --
  • Michael A Kelly
  • Independent Director
  • 164.16K
  • Dr. Wendy K. Chung, M.D.
  • Independent Director
  • 161.66K
  • Dr. Thomas Cahill
  • Independent Director
  • 11.88K
  • Robert Taylor Nelsen
  • Independent Director
  • 11.50K
  • Dr. David P. Schenkein, M.D.
  • Independent Director
  • 11.50K
  • Kaye Foster
  • Independent Director
  • 261.68K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg